MoneyWorks4Me

Panacea Biotec files suit seeking to restrain Sanofi from marketing fully liquid hexavalent vaccine

18 May 2021 Evaluate

Panacea Biotec has filed a suit before the Delhi High Court seeking to restrain Sanofi Healthcare India from marketing a fully liquid hexavalent vaccine. A case has been filed in order to stop infringement of its patent for fully liquid whole cell pertussis based fully liquid Hexavalent vaccine EasySix.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..